LPBC yields 3.56% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, LPBC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LPBC + ABBV for your $10,000?
Lincoln Park Bancorp. operates as the holding company for Lincoln 1st Bank that provides banking products and services in the United States. The company offers checking and saving accounts, such as passbook savings accounts, individual retirement accounts, statement savings accounts, money market deposit accounts, holiday and vacation club accounts, student saver accounts, interest bearing now checking accounts, New Jersey consumer checking accounts, small business checking accounts, and certificates of deposit. It also provides loans, including mortgage loans, home equity loans, home equity lines of credit, personal auto loans, passbook loans, overdraft credit reserve accounts, residential construction loans, commercial mortgage loans, small business lines of credit, small business term loans, and small business short term notes. In addition, the company offers various other services consisting of direct deposits, safe deposit boxes, notary services, medallion signature guaranty, wire transfers, night deposits, ATM cards, credit and debit cards, and money orders. It operates through 2 branch locations in Lincoln Park and Montville, New Jersey. Lincoln Park Bancorp. was founded in 1923 and is headquartered in Pine Brook, New Jersey. Lincoln Park Bancorp. operates as a subsidiary of Lincoln Park Bancorp, MHC.
Full LPBC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.